Skip to main content
Log in

Bee venom allergy immunotherapy

Anaphylactic reaction: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lourenco T, et al. Omalizumab in immunotherapy with hymenoptera venom. Allergy 72: 684 abstr. 1249, Aug 2017. Available from: URL: http://doi.org/10.1111/all.13252 [abstract] - Portugal

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bee venom allergy immunotherapy. Reactions Weekly 1671, 78 (2017). https://doi.org/10.1007/s40278-017-36512-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-36512-9

Navigation